Perrigo Company plc (LON:0Y5E)
25.33
-0.06 (-0.25%)
At close: Feb 21, 2025
Perrigo Company Revenue
Perrigo Company had revenue of $1.09B USD in the quarter ending September 28, 2024, a decrease of -3.23%. This brings the company's revenue in the last twelve months to $4.39B, down -5.63% year-over-year. In the year 2023, Perrigo Company had annual revenue of $4.66B with 4.58% growth.
Revenue (ttm)
$4.39B
Revenue Growth
-5.63%
P/S Ratio
n/a
Revenue / Employee
$480.53K
Employees
9,140
Market Cap
2.73B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
Dec 31, 2019 | 3.87B | -861.80M | -18.21% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Jun 27, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Perrigo Company News
- 19 days ago - Perrigo Co PLC (PRGO) Expands Reproductive Health Initiative with WNBA Partnership - GuruFocus
- 19 days ago - Opill® extends mission of breaking down birth control barriers with launch of multi-state college tour and expansion of partnerships - PRNewsWire
- 23 days ago - Perrigo to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025, Host Virtual Investor Day on February 28, 2025 - PRNewsWire
- 26 days ago - Perrigo Paves The Way For Recovery With Margin Focus - Seeking Alpha
- 4 weeks ago - Perrigo: A Consumer Health Company Close To An Inflection Point - Seeking Alpha
- 6 weeks ago - Perrigo Co PLC Expands Scientific Office and Appoints New Chief Scientific Officer - GuruFocus
- 6 weeks ago - Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific Officer - PRNewsWire
- 2 months ago - Insider Sell: Jeffrey Kindler Sells Shares of Perrigo Co PLC - GuruFocus